Skip to main content

Advertisement

SpringerLink
Log in

New insights into central nervous system lupus: A clinical perspective

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Patients with systemic lupus erythematosus (SLE) experience a wide array of neurologic (N) and psychiatric (P) events, some of which are directly attributable to lupus. Regardless of attribution, NP events have a significant impact on individual patient’s health-related quality of life. Primary immunopathogenic mechanisms of NP-SLE include vasculopathy, autoantibody production, and intrathecal inflammatory mediators. The recently described anti-NR2 glutamate receptor antibodies have been implicated in animal models of neuronal injury, but their role in the pathogenesis of human NP-SLE is unclear. The diagnosis of NP-SLE remains largely one of exclusion, although the detection of select autoantibodies, CSF analysis, and appropriate use of neuroimaging and neuropsychometric testing may provide support in the evaluation of individual patients. Therapeutic options include symptomatic therapies, immunosuppression, and anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599–608.

  2. Ainiala H, Hietaharju A, Loukkola, et al.: Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001, 45:419–423.

    Article  PubMed  CAS  Google Scholar 

  3. Brey RL, Holliday SL, Saklad AR, et al.: Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002, 58:1214–1220.

    PubMed  CAS  Google Scholar 

  4. Hanly JG, McCurdy G, Fougere L, et al.: Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004, 31:2156–2162.

    PubMed  Google Scholar 

  5. Sanna G, Bertolaccini ML, Cuadrado MJ, et al.: Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003, 30:985–992.

    PubMed  Google Scholar 

  6. Sibbitt WL Jr, Brandt JR, Johnson CR, et al.: The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002, 29:1536–1542.

    PubMed  Google Scholar 

  7. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al.: Neuropsychiatric events at diagnosis of systemic lupus erythematosus. An international, inception cohort study. Arthritis Rheum 2007, 56:265–273.

    Article  PubMed  CAS  Google Scholar 

  8. Hanly JG, Fisk JD, McCurdy G, et al.: Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2005, 32:1459–1466.

    PubMed  Google Scholar 

  9. Jonsen A, Bengtsson AA, Nived O, et al.: Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford) 2002, 41:1308–1312.

    Article  CAS  Google Scholar 

  10. Hanly JG, Cassell K, Fisk JD: Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 1997, 40:1542–1543.

    Article  PubMed  CAS  Google Scholar 

  11. Hanly JG, Fisk JD, Sherwood G, et al.: Clinical course of cognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1994, 21:1825–1831.

    PubMed  CAS  Google Scholar 

  12. Ginsburg KS, Wright EA, Larson MG, et al.: A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 1992, 35:776–782.

    Article  PubMed  CAS  Google Scholar 

  13. Karassa FB, Ioannidis JP, Boki KA, et al.: Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 2000, 109:628–634.

    Article  PubMed  CAS  Google Scholar 

  14. Mikdashi J, Handwerger B: Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 2004, 43:1555–1560.

    Article  CAS  Google Scholar 

  15. Hanly JG: Neuropsychiatric lupus. Rheum Dis Clin North Am 2005, 31:273–298.

    Article  PubMed  Google Scholar 

  16. Hanly JG, Harrison MJ: Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 2005, 19:799–821.

    Article  PubMed  Google Scholar 

  17. Kowal C, DeGiorgio LA, Nakaoka T, et al.: Cognition and immunity; antibody impairs memory. Immunity 2004, 21:179–188.

    Article  PubMed  CAS  Google Scholar 

  18. DeGiorgio LA, Konstantinov KN, Lee SC, et al.: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001, 7:1189–1193.

    Article  PubMed  CAS  Google Scholar 

  19. Omdal R, Brokstad K, Waterloo K, et al.: Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005, 12:392–398.

    Article  PubMed  CAS  Google Scholar 

  20. Hanly JG, Robichaud J, Fisk JD: Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 2006, 33:1553–1558.

    PubMed  CAS  Google Scholar 

  21. Harrison MJ, Ravdin LD, Lockshin MD: Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 2006, 54:2515–2522.

    Article  PubMed  CAS  Google Scholar 

  22. Lapteva L, Nowak M, Yarboro CH, et al.: Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006, 54:2505–2514.

    Article  PubMed  CAS  Google Scholar 

  23. Yoshio T, Onda K, Nara H, et al.: Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2006, 54:675–678.

    Article  PubMed  CAS  Google Scholar 

  24. Hirohata S, Miyamoto T: Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990, 33:644–649.

    Article  PubMed  CAS  Google Scholar 

  25. Shiozawa S, Kuroki Y, Kim M, et al.: Interferon-alpha in lupus psychosis. Arthritis Rheum 1992, 35:417–422.

    Article  PubMed  CAS  Google Scholar 

  26. Ainiala H, Hietaharju A, Dastidar P, et al.: Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum 2004, 50:858–865.

    Article  PubMed  CAS  Google Scholar 

  27. Trysberg E, Blennow K, Zachrisson O, et al.: Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res Ther 2004, 6:R551–556.

    Article  PubMed  CAS  Google Scholar 

  28. Trysberg E, Nylen K, Rosengren LE, et al.: Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 2003, 48:2881–2887.

    Article  PubMed  Google Scholar 

  29. Denburg SD, Denburg JA: Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 2003, 12:883–890.

    Article  PubMed  CAS  Google Scholar 

  30. Hanly JG, Liang MH: Cognitive disorders in systemic lupus erythematosus. Epidemiologic and clinical issues. Ann N Y Acad Sci 1997, 823:60–68.

    Article  PubMed  CAS  Google Scholar 

  31. Roebuck-Spencer TM, Yarboro C, Nowak M, et al.: Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis Rheum 2006, 55:434–441.

    Article  PubMed  Google Scholar 

  32. Sibbitt WL Jr, Sibbitt RR, Brooks WM: Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999, 42:2026–2038.

    Article  PubMed  Google Scholar 

  33. Bell CL, Partington C, Robbins M, et al.: Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum 1991, 34:432–441.

    Article  PubMed  CAS  Google Scholar 

  34. Hanly JG: Evaluation of patients with CNS involvement in SLE. Baillieres Clin Rheumatol 1998, 12:415–431.

    Article  PubMed  CAS  Google Scholar 

  35. Bosma GP, Middelkoop HA, Rood MJ, et al.: Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2002, 46:2665–2672.

    Article  PubMed  Google Scholar 

  36. Bosma GP, Huizinga TW, Mooijaart SP, et al.: Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol 2003, 24:850–854.

    PubMed  Google Scholar 

  37. Denburg SD, Carbotte RM, Denburg JA: Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 1994, 37:1311–1320.

    Article  PubMed  CAS  Google Scholar 

  38. Barile L, Lavalle C: Transverse myelitis in systemic lupus erythematosus—the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 1992, 19:370–372.

    PubMed  CAS  Google Scholar 

  39. Eyanson S, Passo MH, Aldo-Benson MA, et al.: Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann Rheum Dis 1980, 39:377–380.

    Article  PubMed  CAS  Google Scholar 

  40. Mok CC, Lau CS, Wong RW: Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study. Am J Med 2003, 115:59–62.

    Article  PubMed  CAS  Google Scholar 

  41. Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, et al.: Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005, 64:620–625.

    Article  PubMed  CAS  Google Scholar 

  42. Sanna G, Bertolaccini ML, Cuadrado MJ, et al.: Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) 2003, 42:200–213.

    Article  CAS  Google Scholar 

  43. Crowther MA, Ginsberg JS, Julian J, et al.: A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003, 349:1133–1138.

    Article  PubMed  CAS  Google Scholar 

  44. McLaurin EY, Holliday SL, Williams P, et al.: Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005, 64:297–303.

    PubMed  CAS  Google Scholar 

  45. Harrison MJ, Morris KA, Horton R, et al.: Results of intervention for lupus patients with self-perceived cognitive difficulties. Neurology 2005, 65:1325–1327.

    Article  PubMed  CAS  Google Scholar 

  46. Hanly JG: Neuropsychiatric lupus. Curr Rheumatol Rep 2001, 3:205–212.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, Dalhousie, University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada, B3H 4K4

    John G. Hanly MD

Authors
  1. John G. Hanly MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John G. Hanly MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanly, J.G. New insights into central nervous system lupus: A clinical perspective. Curr Rheumatol Rep 9, 116–124 (2007). https://doi.org/10.1007/s11926-007-0005-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-007-0005-2

Keywords

Search

Navigation